Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Mater Sci Eng C Mater Biol Appl ; 70(Pt 1): 250-257, 2017 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-27770888

RESUMO

Mini-tablets are a new tendency in solid dosage form design for overcoming therapeutic obstacles such as impaired swallowing and polypharmacy therapy. Among their advantages, these systems offer therapeutic benefits such as dose flexibility and combined drug release patterns. The use of lipids in the formulation has also drawn considerable interest as means to modify the drug release from the dosage form. Therefore, this paper aimed at developing sustained release mini-tablets containing the highly soluble drugs captopril and metformin hydrochloride. Carnauba wax was used as a lipid component in melt granulation, targeting the improvement of the drugs poor flowability and tabletability, as well as to sustain the drug release profiles in association with other excipients. To assist sustaining the drug release, Ethocel™ (EC) and Kollicoat® SR 30D associated with Opadry® II were employed as matrix-forming and reservoir-forming materials, respectively. The neat drugs, granules and the bulk formulations were evaluated for their angle of repose, compressibility index, Hausner ratio and tabletability. Mini-tablets were evaluated for their weight variation, hardness, friability, drug content and in-vitro drug release. The results indicated that melt granulation with carnauba wax improved the flow and the tabletability of the drugs, allowing the preparation of mini-tablets with adequate tensile strength under reduced compaction pressures. All mini-tablet formulations showed acceptable hardness (within the range of 1.16 to 3.93Kp) and friability (<0.1%). The melt-granulated captopril in matrix systems containing 50% EC (45P, 100P or 100FP) and the melt-granulated metformin hydrochloride in reservoir systems coated with Kollicoat® SR 30D and Opadry® II (80:20 with 10% weight gain or 70:30 with 20% weight gain) exhibited release profiles adequate to sustained release formulations, for over 450min. Therefore, carnauba wax proved to be a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of soluble drugs.


Assuntos
Captopril/farmacologia , Liberação Controlada de Fármacos , Excipientes/química , Metformina/farmacologia , Ceras/química , Preparações de Ação Retardada/farmacologia , Cinética , Reologia , Solubilidade , Comprimidos
2.
Mater Sci Eng C Mater Biol Appl ; 53: 229-38, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26042711

RESUMO

Acyclovir, an analog of 2'-deoxyguanosine, is one of the most important drugs in the current approved antiviral treatment. However, it's biopharmaceutical properties, contribute to acyclovir's poor oral bioavailability, which restricts the clinical use of the drug. In this view, the aim of this work was to improve the dissolution rate and intestinal permeability of acyclovir through the development of ball milling solid dispersions with the hydrophilic carriers Pluronic F68®, hydroxypropylmethyl cellulose K100M® and chitosan. Solid dispersions were obtained and completely characterized through different solid state techniques. The solid state data demonstrated a decrease in the crystallinity (amorphous phase and defects) and the presence of hydrogen bonds for SD HPMC and SD CTS. The enhancement of dissolution rates was observed for all SDs developed. In addition, no detrimental effects over the in vitro antiviral activity were detected. The solid dispersions with Pluronic F68® significantly improved the intestinal permeability of acyclovir across Caco-2 cells. In summary, the SDs developed in this study could be considered as potential systems for solid dosage forms containing acyclovir with superior biopharmaceutical properties.


Assuntos
Aciclovir/química , Aciclovir/farmacocinética , Portadores de Fármacos/química , Modelos Biológicos , Células CACO-2 , Portadores de Fármacos/farmacocinética , Portadores de Fármacos/farmacologia , Absorção Gastrointestinal , Humanos , Permeabilidade
3.
Rev. bras. farmacogn ; 17(4): 578-582, out.-dez. 2007. ilus, tab
Artigo em Português | LILACS | ID: lil-476208

RESUMO

A planta Plinia glomerata (Myrtaceae), popularmente conhecida como cabeludinha ou " jabuticaba-amarela" , ocorre amplamente no sul do Brasil e é cultivada como ornamental e frutífera comestível. O presente trabalho avaliou as propriedades antimicrobianas dos extratos, frações e substâncias puras isoladas da planta contra bactérias e fungos patogênicos. As concentrações inibitórias mínimas (CIM) foram determinadas através do método de diluição em ágar. As frações acetato de etila (AE) e fração aquosa (AQ) demonstraram a melhor atividade contra Staphylococcus aureus. A fração AQ também foi efetiva contra Escherichia coli. As substâncias puras, ácido 3,4,3'-trimetóxi-flavelágico-4'-O-glicosídeo e ácido 3,4,3'-trimetóxi-flavelágico foram inativas até a concentração de 500 µg/mL contra os microrganismos testados. Em relação aos resultados antifúngicos, os extratos metanólico (EM) e acetônico (EA) e a fração aquosa (AQ) mostraram boa atividade somente contra dermatófitos. Os resultados obtidos permitem concluir que a Plinia glomerata possui princípios ativos com ação antimicrobiana, sugerindo que outras substâncias da planta estão agindo contra os microrganismos indicados ou a existência de efeitos sinérgicos.


Plinia glomerata, commonly known as " yellow jaboticaba" or " cabelluda" occurs widely in south of Brazil. This work evaluated the antimicrobial properties of the extracts, fractions and isolated compounds of this plant against pathogenic microorganisms, bacteria and fungi. The minimal inhibitory concentration (MIC) was determined through the method of dilution in agar. The ethyl acetate (EtOAc) and aqueous fractions demonstrated the best activity against Staphylococcus aureus. The aqueous fraction also exhibited good activity against Escherichia coli. The pure substances 3,4,3'-trimethoxy-flavellagic-4'-O-glucose acid and 3,4,3'-trimethoxy-flavellagic acid were inactive up to 500 µg/mL. Regarding results against fungi, EA and EM extracts as well as AQ fraction showed good activity only against dermatophytes. The results suggest that P. glomerata produces active principles with antimicrobial activity, suggesting that other substances from the plant are acting against the microorganisms or the existence of synergic effects.


Assuntos
Bactérias , Extratos Vegetais/farmacologia , Fungos , Myrtaceae , Myrtaceae/química
4.
Z Naturforsch C J Biosci ; 62(3-4): 196-200, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17542484

RESUMO

The present work describes the antinociceptive properties and chemical composition of the aerial parts of Plinia glomerata (Myrtaceae). Both of the extracts evaluated, acetonic and methanolic, showed potent antinociceptive action, when analyzed against acetic acid-induced abdominal constrictions in mice, with calculated ID50 (mg/kg, i. p.) values of 24.8 and 3.3, respectively. Through usual chromatographic techniques with an acetonic extract, the following compounds were obtained: 3,4,3'-trimethoxy flavellagic acid (1), 3,4,3'-trimethoxy flavellagic acid 4'-O-glucoside (3) and quercitrin (4), which were identified based on spectroscopic data. Compounds 1 (ID50 = 3.9 mg/kg, i. p., or 10.8 micromol/kg) and 3 (ID50 = 1.3 mg/kg or 2.5 micromol/kg) were notably more active than some well-known analgesic drugs used here for comparison.


Assuntos
Analgésicos/farmacologia , Myrtaceae/química , Fenóis/farmacologia , Componentes Aéreos da Planta/química , Acetaminofen/farmacologia , Analgésicos/química , Analgésicos/isolamento & purificação , Animais , Aspirina/farmacologia , Brasil , Diclofenaco/farmacologia , Dipirona/farmacologia , Espectroscopia de Ressonância Magnética , Masculino , Camundongos , Modelos Moleculares , Fenóis/química , Fenóis/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA